Prometheus Biosciences, Inc

/Prometheus Biosciences, Inc

We are a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD).

Symbol

Price Range
$18.00 - $19.00

Final Shares
9,000,000

Anticipated Date
March 12, 2021

Underwriters

This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange